- Home
- CRMD vs CRON Comparison
CRMD vs CRON Comparison
Compare CRMD & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- CRON
- Stock Information
- Founded
- CRMD 2006
- CRON N/A
- Country
- CRMD United States
- CRON Canada
- Employees
- CRMD N/A
- CRON N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- CRON Medicinal Chemicals and Botanical Products
- Sector
- CRMD Health Care
- CRON Health Care
- Exchange
- CRMD Nasdaq
- CRON Nasdaq
- Market Cap
- CRMD 876.7M
- CRON 961.2M
- IPO Year
- CRMD 2010
- CRON N/A
- Fundamental
- Price
- CRMD $9.79
- CRON $2.38
- Analyst Decision
- CRMD Strong Buy
- CRON
- Analyst Count
- CRMD 7
- CRON 0
- Target Price
- CRMD $17.43
- CRON N/A
- AVG Volume (30 Days)
- CRMD 3.1M
- CRON 1.3M
- Earning Date
- CRMD 11-12-2025
- CRON 11-06-2025
- Dividend Yield
- CRMD N/A
- CRON N/A
- EPS Growth
- CRMD N/A
- CRON N/A
- EPS
- CRMD 2.25
- CRON 0.09
- Revenue
- CRMD $214,303,672.00
- CRON $132,357,000.00
- Revenue This Year
- CRMD $565.64
- CRON $19.67
- Revenue Next Year
- CRMD $46.09
- CRON $30.56
- P/E Ratio
- CRMD $4.30
- CRON $25.17
- Revenue Growth
- CRMD 1647.67
- CRON 19.00
- 52 Week Low
- CRMD $5.60
- CRON $1.60
- 52 Week High
- CRMD $17.43
- CRON $3.16
- Technical
- Relative Strength Index (RSI)
- CRMD 38.57
- CRON 44.83
- Support Level
- CRMD $9.45
- CRON $2.43
- Resistance Level
- CRMD $10.40
- CRON $2.58
- Average True Range (ATR)
- CRMD 0.68
- CRON 0.08
- MACD
- CRMD -0.14
- CRON -0.01
- Stochastic Oscillator
- CRMD 13.66
- CRON 35.94
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About CRON Cronos Group Inc.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.